CN1931340A - Leukoderma treating Chinese medicine prepn - Google Patents
Leukoderma treating Chinese medicine prepn Download PDFInfo
- Publication number
- CN1931340A CN1931340A CN 200610140568 CN200610140568A CN1931340A CN 1931340 A CN1931340 A CN 1931340A CN 200610140568 CN200610140568 CN 200610140568 CN 200610140568 A CN200610140568 A CN 200610140568A CN 1931340 A CN1931340 A CN 1931340A
- Authority
- CN
- China
- Prior art keywords
- parts
- stir
- baked
- chinese medicine
- vinegar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 45
- 206010024380 Leukoderma Diseases 0.000 title abstract description 4
- 238000002360 preparation method Methods 0.000 claims abstract description 18
- 210000000582 semen Anatomy 0.000 claims description 42
- 239000000052 vinegar Substances 0.000 claims description 28
- 235000021419 vinegar Nutrition 0.000 claims description 28
- 241000628997 Flos Species 0.000 claims description 14
- 239000009636 Huang Qi Substances 0.000 claims description 14
- 239000012266 salt solution Substances 0.000 claims description 14
- 150000003839 salts Chemical class 0.000 claims description 14
- 239000002994 raw material Substances 0.000 claims description 10
- 241000545442 Radix Species 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 9
- 241000209501 Spirodela Species 0.000 claims description 7
- 239000002775 capsule Substances 0.000 claims description 7
- 239000008187 granular material Substances 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 239000003826 tablet Substances 0.000 claims description 6
- 239000006196 drop Substances 0.000 claims description 5
- -1 electuary Substances 0.000 claims description 5
- 229940023488 pill Drugs 0.000 claims description 5
- 239000006187 pill Substances 0.000 claims description 5
- 239000002552 dosage form Substances 0.000 claims description 4
- 229940046011 buccal tablet Drugs 0.000 claims description 3
- 239000006189 buccal tablet Substances 0.000 claims description 3
- 239000000243 solution Substances 0.000 claims description 3
- 239000008280 blood Substances 0.000 abstract description 21
- 230000000694 effects Effects 0.000 abstract description 21
- 210000004369 blood Anatomy 0.000 abstract description 20
- 210000004185 liver Anatomy 0.000 abstract description 14
- 210000003734 kidney Anatomy 0.000 abstract description 8
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 230000006870 function Effects 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 230000001105 regulatory effect Effects 0.000 abstract description 2
- 238000010792 warming Methods 0.000 abstract description 2
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 240000009138 Curcuma zedoaria Species 0.000 abstract 1
- 235000003405 Curcuma zedoaria Nutrition 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 241000913745 Spatholobus Species 0.000 abstract 1
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 abstract 1
- 235000019509 white turmeric Nutrition 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 23
- 208000002193 Pain Diseases 0.000 description 16
- 230000036407 pain Effects 0.000 description 14
- 206010047642 Vitiligo Diseases 0.000 description 13
- 239000000796 flavoring agent Substances 0.000 description 13
- 235000019634 flavors Nutrition 0.000 description 13
- 206010025421 Macule Diseases 0.000 description 10
- 230000007812 deficiency Effects 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 201000000736 Amenorrhea Diseases 0.000 description 6
- 206010001928 Amenorrhoea Diseases 0.000 description 6
- 231100000540 amenorrhea Toxicity 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 206010040882 skin lesion Diseases 0.000 description 6
- 231100000444 skin lesion Toxicity 0.000 description 6
- 208000006820 Arthralgia Diseases 0.000 description 5
- 210000001015 abdomen Anatomy 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 230000027939 micturition Effects 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 208000005171 Dysmenorrhea Diseases 0.000 description 4
- 206010013935 Dysmenorrhoea Diseases 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 230000008736 traumatic injury Effects 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 206010042674 Swelling Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 239000007844 bleaching agent Substances 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 210000004877 mucosa Anatomy 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010061245 Internal injury Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010059013 Nocturnal emission Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000035614 depigmentation Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 206010019847 hepatosplenomegaly Diseases 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 201000002364 leukopenia Diseases 0.000 description 2
- 231100001022 leukopenia Toxicity 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010006002 Bone pain Diseases 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 206010009346 Clonus Diseases 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 241001313288 Labia Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047631 Vitamin E deficiency Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 229940119577 blood stop Drugs 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- NKWPZUCBCARRDP-UHFFFAOYSA-L calcium bicarbonate Chemical compound [Ca+2].OC([O-])=O.OC([O-])=O NKWPZUCBCARRDP-UHFFFAOYSA-L 0.000 description 1
- 229910000020 calcium bicarbonate Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000002662 enteric coated tablet Substances 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000007941 film coated tablet Substances 0.000 description 1
- 210000004905 finger nail Anatomy 0.000 description 1
- 210000003953 foreskin Anatomy 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000031169 hemorrhagic disease Diseases 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000004379 myopia Effects 0.000 description 1
- 208000001491 myopia Diseases 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 230000001613 neoplastic effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 201000008968 osteosarcoma Diseases 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 235000002378 plant sterols Nutrition 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 208000018299 prostration Diseases 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011127 radiochemotherapy Methods 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 238000009666 routine test Methods 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 150000003376 silicon Chemical class 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 238000009495 sugar coating Methods 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Abstract
The leukoderma treating Chinese medicine preparation is prepared with burred tuber, zedoary, peach kernel, safflower, spatholobus stem and other seven kinds of Chinese medicinal materials. It has the functions of warming and invigorating liver and kidney, dispelling wind and wetness, regulating blood and qi, and moistening skin. It has determined curative effect on leukoderma, no toxic side effect, taking convenience and low cost.
Description
Technical field
The present invention relates to the leukodermic Chinese medicine preparation of a kind of treatment, is that a kind of vitiligo for the treatment of is the Chinese patent medicine of raw material with the Chinese herbal medicine.Belong to the field of Chinese medicines.
Background technology
Vitiligo is a kind of posteriority limitation depigmentation dermatosis.Go down with skin color, bleach, boundary distinctness, no conscious sympton are feature.The same with other pigment anomalies, leukodermic sickness rate is with area, the ethnic group colour of skin and different.The dark more people's sickness rate of general colour is high more, and prevalence is about 0.1～2% in the population of China.The men and women can fall ill until old every year from the newborn baby about equally, but is many with teenager, has data to show that age of onset is in the majority 10～30 years old group, accounts for 62.65% of sum, and women's age of onset was than male about 5 years ahead of time.
Leukodermic clinical manifestation is: the skin at any position all can take place, but good sending out in being subject to solar radiation and frictionally damage position, as facial area, cervical region, trunk and extremity etc.The inboard mucosa of lip, labia, glans penis and foreskin also can involve.Most of leukasmus is symmetrically distributed, also has part patient white macula to distribute along nerve segment.Skin lesion is a limitation depigmentation speckle, milky, from fingernail to the coin size, circular, ellipse or irregular type.White macula place hair also can bleach.In progressive stage, the decolouring speckle is divided a word with a hyphen at the end of a line to normal skin, and development is very fast, and isomorphic response is arranged, and promptly can form the secondary vitiligo after pressure, friction, the wound.
Can divide three types according to leukoderma scope and distribution: 1, the topical type skin lesion is confined to a position, can be divided into 1. segmental pattern again: skin lesion is pressed dermatomere and is distributed; 2. mucosa type: only involve mucosa.2, general hair style is the most common, shows as skin lesion and is distributed widely in body surface, can be divided into 1. homeliness type: skin lesion is dispersed in and is distributed in the body surface many places; 2. face acra type: skin lesion is distributed in face and far-end of limb; 3. mixed type: above-mentioned several various combinations form.As face acra type+segmental pattern etc.3, whole body type, whole skin all decolour fully or almost, also have hair to bleach.
Primary disease is equivalent to leucoderma, the vitiligo of the traditional Chinese medical science.Put down in writing as " General Treatise on the Cause and Symptoms of Diseases " leucoderma: " the leucoderma person, face and neck health skin and flesh complexion changed are white, and be different with meat, the pain of also not itching, the leucoderma of meaning." and for example " the Yizong Jinjian surgery heart shows " vitiligo record: " vitiligo is the face collar humorously, and the ailment said due to cold or exposure white point speckle even all over of fighting does not mutually have the pain of itching, and controls and should fully recover from an illness by the pathogenic wind expelling fat liquoring.”
The traditional Chinese medical science thinks that leukodermic morbidity is outer because experience ailment said due to cold or exposure, injury from falling down; Interior because of feelings will internal injury, hemorrhagic disorder and consumption of essence etc., these can make qi-blood disharmony, and obstruction of collaterals by blood stasis, deficiency of the liver and kindey lead to this disease.So the treatment of the traditional Chinese medical science is to be divided into disease types such as disharmony between QI and blood, retention of damp-heat in the interior, obstruction of collaterals by blood stasis, deficiency of the liver and kindey, stagnation of QI due to depression of the liver to carry out Coryza Treated by Syndrome Differentiation.The leukodermic method of western medical treatment is a lot, but great majority can only reach recent clinical effectiveness, and can not prevent recurrence, and has toxic and side effects in various degree.
Summary of the invention
The present invention develops in conjunction with the latest modern technological scientific achievement on the basis of traditional tcm syndrome differentiation and treatment.The purpose of this invention is to provide the leukodermic Chinese medicine preparation of a kind of treatment, have determined curative effect, safe ready, have no side effect, cheap characteristics.
The present invention is made by the following weight proportion raw material:
2.5～10 parts of 1～4 part of salt Semen Astragali Complanatis of 1～4 part of Flos Carthami of stir-baked RHIZOMA SPARGANII with vinegar
2.5～10 parts of 1～4 part of stir-baked SEMEN PSORALEAE with salt solution of 1～4 portion of Lignum Sappan of stir-baked RHIIZOMA CURCUMAE with vinegar
1.5～6 parts of 1～4 part of Radix Astragali of 1～4 portion of Herba Spirodelae of Semen Persicae (parched)
2.5～10 parts of 1.5～6 parts of Radixs Angelicae Dahuricae of 1.5～6 parts of Rhizoma Chuanxiongs of Caulis Spatholobi
The weight proportion of each raw material of optimization formula of the present invention is:
3～7 parts of 1.5～2.5 parts of salt Semen Astragali Complanatis of 1.5～2.5 parts of Flos Carthamis of stir-baked RHIZOMA SPARGANII with vinegar
3～7 parts of 1.5～2.5 parts of stir-baked SEMEN PSORALEAE with salt solution of 1.5～2.5 portions of Lignum Sappans of stir-baked RHIIZOMA CURCUMAE with vinegar
2.5～3.5 parts of 1.5～2.5 parts of Radix Astragali of 1.5～2.5 portions of Herba Spirodelaes of Semen Persicae (parched)
3～7 parts of 2.5～3.5 parts of Radixs Angelicae Dahuricae of 2.5～3.5 parts of Rhizoma Chuanxiongs of Caulis Spatholobi
The weight proportion of each raw material of optimum formula of the present invention is:
5 parts of 2 parts of salt Semen Astragali Complanatis of 2 parts of Flos Carthamis of stir-baked RHIZOMA SPARGANII with vinegar
5 parts of 2 parts of stir-baked SEMEN PSORALEAE with salt solution of 2 portions of Lignum Sappans of stir-baked RHIIZOMA CURCUMAE with vinegar
3 parts of 2 parts of Radix Astragali of 2 portions of Herba Spirodelaes of Semen Persicae (parched)
5 parts of 3 parts of Radixs Angelicae Dahuricae of 3 parts of Rhizoma Chuanxiongs of Caulis Spatholobi
Drug action mechanism among the present invention is as follows:
Stir-baked RHIZOMA SPARGANII with vinegar nature and flavor suffering, hardship, flat.Return liver, spleen channel.Has removing blood stasis, circulation of qi promoting, removing food stagnancy analgesic effect.Can treat lump in the abdomen, coagulation of QI-blood, trusted subordinate's pain, the food stagnation distending pain, the side of body expands down painful, amenorrhea, dysmenorrhea, puerperal abdominalgia with blood stasis, traumatic injury, skin ulcer is swollen hard, hepatosplenomegaly etc.(Ji Yubin chief editor " Chinese medicine medicine for preventing pharmacology and application " Heilungkiang science tech publishing house 1999 version the 69th page).
Stir-baked RHIIZOMA CURCUMAE with vinegar nature and flavor hardship, suffering, temperature.Return liver, spleen channel.Have the circulation of qi promoting removing blood stasis with potent drugs, the removing food stagnancy pain relieving is changed poly-eliminating mass, antiearly pregnancy, antineoplastic effect.Can treat that trusted subordinate's distending pain, lump in the abdomen, dyspepsia do not disappear, hepatosplenomegaly, abdominal pain due to blood stasis, amenorrhea due to stagnation of blood, cervical erosion, traumatic injury have a pain etc.(Ji Yubin chief editor " Chinese medicine medicine for preventing pharmacology and application " Heilungkiang science tech publishing house 1999 version the 995th page).
Semen Persicae (parched) nature and flavor hardship, sweet, flat.GUIXIN, liver, large intestine channel.Has blood stasis removing and clots absorbing, the effect of loosening bowel to relieve constipation.Can control amenorrhea, dysmenorrhea, mass in the abdomen, calentura blood-retention, migratory arthralgia, malaria, traumatic injury, swelling and pain due to blood stasis, the dry constipation of blood etc.(Ji Yubin chief editor " Chinese medicine medicine for preventing pharmacology and application " Heilungkiang science tech publishing house 1999 version the 986th page).
Flos Carthami nature and flavor suffering, temperature.GUIXIN, Liver Channel.Effect with promoting blood circulation to restore menstrual flow, eliminating stasis to stop pain.Can treat that amenorrhea, lump in the abdomen, difficult labour, stillborn fetus, disease that postpartum lochia can't go, blood stasis are had a pain, carbuncle, traumatic injury etc.(Ji Yubin chief editor " Chinese medicine medicine for preventing pharmacology and application " Heilungkiang science tech publishing house 1999 version the 604th page).
Caulis Spatholobi nature and flavor hardship, sweet, warm.Return liver, kidney channel.Have and enrich blood, invigorate blood circulation, the effect of collateral dredging.Can treat menoxenia, blood deficiency and yellow complexion, paralysis and numbness, rheumatic arthralgia etc.(the 151st page of Chemical Industry Press of Pharmacopoeia of the People's Republic of China version in 2000 is compiled by Chinese Pharmacopoeia Commission).
The Lignum Sappan nature and flavor are sweet, salty, and are flat.GUIXIN, liver, spleen channel.Has the promoting the circulation of blood blood stasis dispelling, the effect of reducing swelling and alleviating pain.Can treat the amenorrhea dysmenorrhea, postpartum stagnation, breast ventral spine pain, wound swell and ache etc.(the 130th page of Chemical Industry Press of Pharmacopoeia of the People's Republic of China version in 2000 is compiled by Chinese Pharmacopoeia Commission).
Herba Spirodelae nature and flavor suffering, cold.Return lung meridian.Has dispelling wind-heat, rash, diuretic effect.Can treat measles without adequate eruption, rubella pruritus, edema oliguria etc.(the 243rd page of Chemical Industry Press of Pharmacopoeia of the People's Republic of China version in 2000 is compiled by Chinese Pharmacopoeia Commission).
Rhizoma Chuanxiong nature and flavor suffering, perfume (or spice).Return liver, gallbladder, pericardium channel.Has blood-activating and qi-promoting, the effect of wind-expelling pain-stopping.Can treat menoxenia, the amenorrhea dysmenorrhea, difficult labour produces stasis of blood stop block pain, lump in the abdomen stomachache, the twinge of the breast side of body, arthralgia due to cold clonic spasm of the muscle, tumbling and swelling, headache due to pathogenic wind-heat, rheumatic arthralgia, skin infection swells and ache, placenta retention, cerebral ischemia, coronary heart disease, angina pectoris, atherosclerosis, hypertension, radiotherapy, leukopenia due to the chemotherapy, juvenile myopia, vitamin e deficiency, flu is dizzy, external plug nose treating malaria disease etc.(Ji Yubin chief editor " Chinese medicine medicine for preventing pharmacology and application " Heilungkiang science tech publishing house 1999 version the 171st page).
Radix Angelicae Dahuricae nature and flavor suffering, temperature.Return stomach, large intestine, lung meridian.Has diffusing wind dehumidifying, understand things pain-stopping, the effect of detumescence and apocenosis.Can treat headache due to common cold, supraorbital bone pain, nasal obstruction, nasal sinusitis, toothache, leucorrhea, skin infection swells and ache etc.(the 79th page of Chemical Industry Press of Pharmacopoeia of the People's Republic of China version in 2000 is compiled by Chinese Pharmacopoeia Commission).
Salt Semen Astragali Complanati nature and flavor are sweet, temperature.Return liver, kidney channel.Has the temperature compensation Liver and kidney, controlling nocturnal emission with astringent drugs, reducing urination, the effect that makes eye bright.Can treat lumbago due to renal deficiency, seminal emission premature ejaculation, nebulousurine leukorrhagia, dribbling urination, dizzy blurred vision etc.(the 145th page of Chemical Industry Press of Pharmacopoeia of the People's Republic of China version in 2000 is compiled by Chinese Pharmacopoeia Commission).
Stir-baked SEMEN PSORALEAE with salt solution nature and flavor suffering, hardship, temperature.Return kidney, spleen channel.Have kidney invigorating and YANG supporting, the controlling nocturnal emission with astringent drugs reducing urination, warming spleen and stopping diarrha, the effect of improving inspiration by invigorating kidney-QI.Can treat that osteosarcoma, neoplastic bone shift, leukopenia, hemorrhagic illness, vitiligo, the cold diarrhea of suffering from a deficiency of the kidney, the enuresis, spermatorrhea, frequent micturition, sexual impotence, chills and pain of the waist and kness, frequent micturition, deficiency and coldness are breathed heavily and are coughed etc. behind the chemotherapy radiotherapy.(Ji Yubin chief editor " Chinese medicine medicine for preventing pharmacology and application " Heilungkiang science tech publishing house 1999 version the 714th page).
The Radix Astragali nature and flavor are sweet, warm.Return lung, spleen channel.Have benefit and defend consolidating superficial resistance, inducing diuresis to remove edema, poison holding, the effect of granulation promoting.What be used for that internal injury overstrain, diarrhea due to hypofunction of the spleen, proctoptosis, deficiency of vital energy blood prostration, metrorrhagia and leukorrhagia, spontaneous perspiration, night sweat, arthralgia due to stagnation of blood, edema, carbuncle do not burst or burst does not hold back and the disease of all weakness of QI blood deficiency.(Ji Yubin chief editor " Chinese medicine medicine for preventing pharmacology and application " Heilungkiang science tech publishing house 1999 version the 1074th page).
The present invention follows the principles of formulating prescriptions of the traditional Chinese medical science " monarch ", is monarch drug with stir-baked RHIZOMA SPARGANII with vinegar, stir-baked RHIIZOMA CURCUMAE with vinegar, the Radix Angelicae Dahuricae, salt Semen Astragali Complanati, stir-baked SEMEN PSORALEAE with salt solution, and Semen Persicae (parched), Flos Carthami, Caulis Spatholobi, Rhizoma Chuanxiong and Radix Astragali are ministerial drug, and Lignum Sappan and Herba Spirodelae are adjuvant.All medicines have the temperature compensation Liver and kidney mutually and altogether, the effect of loose wind dehumidifying, QI and blood regulating, the white and moist skin that disappears, treatment and prevention vitiligo, and determined curative effect has no side effect, and taking convenience is cheap.
Chinese medicine preparation of the present invention, can add the medicine acceptable carrier when being prepared into medicament, described medicine acceptable carrier can be: starch, sucrose, lactose, mannitol, silicon derivative, cellulose family and derivant thereof, alginate, gelatin, polyvinylpyrrolidone, glycerol, soil temperature 80, agar, calcium carbonate, calcium bicarbonate, surfactant, Polyethylene Glycol, cyclodextrin, beta-schardinger dextrin-, phospholipid material, Kaolin, Pulvis Talci, calcium stearate, magnesium stearate etc.
Chinese medicine preparation of the present invention can be any pharmaceutically useful dosage form, and these dosage forms comprise: tablet, sugar coated tablet, film coated tablet, enteric coated tablet, capsule, hard capsule, soft capsule, oral liquid, buccal tablet granule, electuary, pill, powder, unguentum, sublimed preparation, suspensoid, powder, solution, injection, suppository, ointment, plaster, cream, spray, drop, patch.Preparation of the present invention, peroral dosage form preferably, as: tablet, capsule, oral liquid, buccal tablet, granule, electuary, pill, powder, suspensoid, powder, solution, drop, drop pill.Preferred Chinese medicine preparation is capsule, tablet, granule.
Clinical drug of the present invention uses the result to show that following advantage is arranged:
1, the Chinese herbal medicine each component selected for use of the present invention meets the regulation of The Drug Administration Law of People's Republic of China, utilizes the comprehensive function treatment and the prevention vitiligo of the Chinese medicine of respectively distinguishing the flavor of, and is nontoxic to human body.Show that through animal acute toxicity experiment the animal of being tested does not see any toxic reaction, its main organs does not have tangible change yet, and safety of medicine is reliable.
2, the present invention need not decoct, no bitterness sense, rich in proteins in the medicine, glucose, glucuronic acid, volatile oil, pectin, fructose, organic acid, lecithin, vitamin, aminoacid, also contain various trace elements such as Saponin, plant sterol and calcium, be beneficial to absorption of human body, health invigorating, and taking convenience.
3, the present invention not only can effectively treat vitiligo, and leukodermic prevention is also had good effect, has improved patient's life quality greatly, and higher healing rehabilitation efficacy is arranged.
Further specify medicine of the present invention to treatment therapy for vitiligo effect below by the clinical practice example.
Vitiligo curative effect determinate standard (the 228th page of Chen Qin chief editor " research and development of Chinese medicine cosmetic health product " Chinese Medicine science and technology publishing house version in 1999.)
(1) recovery from illness: the white macula complete obiteration, histopathology of skin checks normal.
(2) produce effects: white macula disappears more than 50%, and white macula disappearance portion of tissue pathological examination is normal.
(3) effective: white macula disappearance person accounts for 20%～50% of former white macula area, or sees have than the polychrom island in white macula.
(4) invalid: no change or white macula enlarge before and after the treatment.
As follows through clinical test results; Treatment patients with vitiligo 69 examples, male's 26 examples, women's 43 examples, the age is 10～45 years old.Take embodiment 1 capsule, each 2-10 grain, every day three to four times, eliminating cold for resuscitation water send down, and take half an hour ante cibum.Two months is a course of treatment, take continuously three the course of treatment observe the curative effect.58 examples of fully recovering account for 84%, and produce effects 5 examples account for 7.2%, and effective 4 examples account for 5.8%, and invalid 2 examples account for 2.89%, and total effective rate reaches more than 97%.After three course of therapy, the patient skin white macula disappears in various degree or fully recovers.And patient does not have any untoward reaction, and three big routine tests and hepatic and renal function detect no abnormal.
The specific embodiment
Embodiment 1 capsule takes by weighing raw material by following weight:
5 parts of 2 parts of salt Semen Astragali Complanatis of 2 parts of Flos Carthamis of stir-baked RHIZOMA SPARGANII with vinegar
5 parts of 2 parts of stir-baked SEMEN PSORALEAE with salt solution of 2 portions of Lignum Sappans of stir-baked RHIIZOMA CURCUMAE with vinegar
3 parts of 2 parts of Radix Astragali of 2 portions of Herba Spirodelaes of Semen Persicae (parched)
5 parts of 3 parts of Radixs Angelicae Dahuricae of 3 parts of Rhizoma Chuanxiongs of Caulis Spatholobi
Preparation method is to get stir-baked RHIZOMA SPARGANII with vinegar, stir-baked RHIIZOMA CURCUMAE with vinegar, Semen Persicae (parched), Flos Carthami, Caulis Spatholobi, Lignum Sappan, Herba Spirodelae, Rhizoma Chuanxiong, the Radix Angelicae Dahuricae, salt Semen Astragali Complanati, stir-baked SEMEN PSORALEAE with salt solution and Radix Astragali to decoct with water twice, 1.5～2 hours for the first time, 0.5～1 hour for the second time, merge decocting liquid twice, filter, filtrate is concentrated into 80 degree～85 when spending, the clear paste of relative density 1.08～1.10, adding ethanol makes clear paste contain the alcohol amount to reach 70%, left standstill 24 hours, reclaim ethanol, when spending, 50 degree～55 are concentrated into the clear paste of relative density 1.30～1.32, drying is ground into fine powder, incapsulates.Adorn 0.3 gram for every, usually half an hour ante cibum oral, eliminating cold for resuscitation water send down, one time 2～10, three to four times on the one, two months is a course of treatment.
Embodiment 2 tablets take by weighing raw material by following weight:
5 parts of 2 parts of salt Semen Astragali Complanatis of 2 parts of Flos Carthamis of stir-baked RHIZOMA SPARGANII with vinegar
5 parts of 2 parts of stir-baked SEMEN PSORALEAE with salt solution of 2 portions of Lignum Sappans of stir-baked RHIIZOMA CURCUMAE with vinegar
3 parts of 2 parts of Radix Astragali of 2 portions of Herba Spirodelaes of Semen Persicae (parched)
5 parts of 3 parts of Radixs Angelicae Dahuricae of 3 parts of Rhizoma Chuanxiongs of Caulis Spatholobi
Preparation method is to get stir-baked RHIZOMA SPARGANII with vinegar, stir-baked RHIIZOMA CURCUMAE with vinegar, Semen Persicae (parched), Flos Carthami, Caulis Spatholobi, Lignum Sappan, Herba Spirodelae, Rhizoma Chuanxiong, the Radix Angelicae Dahuricae, the salt Semen Astragali Complanati, stir-baked SEMEN PSORALEAE with salt solution and Radix Astragali decoct with water twice, 1.5～2 hours for the first time, 0.5～1 hour for the second time, merge decocting liquid twice, filter, filtrate is concentrated into 80 degree～85 when spending, the clear paste of relative density 1.08～1.10, adding ethanol makes clear paste contain the alcohol amount to reach 70%, left standstill 24 hours, reclaim ethanol, when spending, 50 degree～55 are concentrated into the clear paste of relative density 1.30～1.32, drying is ground into fine powder, adds appropriate amount of starch, alcohol granulation, after the drying, add an amount of magnesium stearate, tabletting, sugar coating are promptly.Usually half an hour ante cibum oral, eliminating cold for resuscitation water send down, one time 2～10, three to four times on the one, two months is a course of treatment.
Embodiment 3 granules take by weighing raw material by following weight:
5 parts of 2 parts of salt Semen Astragali Complanatis of 2 parts of Flos Carthamis of stir-baked RHIZOMA SPARGANII with vinegar
5 parts of 2 parts of stir-baked SEMEN PSORALEAE with salt solution of 2 portions of Lignum Sappans of stir-baked RHIIZOMA CURCUMAE with vinegar
3 parts of 2 parts of Radix Astragali of 2 portions of Herba Spirodelaes of Semen Persicae (parched)
5 parts of 3 parts of Radixs Angelicae Dahuricae of 3 parts of Rhizoma Chuanxiongs of Caulis Spatholobi
Preparation method is to get stir-baked RHIZOMA SPARGANII with vinegar, stir-baked RHIIZOMA CURCUMAE with vinegar, Semen Persicae (parched), Flos Carthami, Caulis Spatholobi, Lignum Sappan, Herba Spirodelae, Rhizoma Chuanxiong, the Radix Angelicae Dahuricae, the salt Semen Astragali Complanati, stir-baked SEMEN PSORALEAE with salt solution and Radix Astragali decoct with water twice, 1.5～2 hours for the first time, 0.5～1 hour for the second time, merge decocting liquid twice, filter, filtrate is concentrated into 80 degree～85 when spending, and the clear paste of relative density 1.08～1.10 adds ethanol and makes clear paste contain the alcohol amount to reach 70%, left standstill 24 hours, reclaim ethanol, when 50 degree～55 are spent, be concentrated into the clear paste of relative density 1.30～1.32, drying, be ground into fine powder, add an amount of sucrose and soluble starch, alcohol granulation, the pack of dry back is promptly.Usually half an hour ante cibum warm boiled water, one time 1～3 bag, three to four times on the one, two months is a course of treatment.
Claims (6)
1, the leukodermic Chinese medicine preparation of a kind of treatment.It is characterized in that it is made by the following weight proportion raw material:
2.5～10 parts of 1～4 part of salt Semen Astragali Complanatis of 1～4 part of Flos Carthami of stir-baked RHIZOMA SPARGANII with vinegar
2.5～10 parts of 1～4 part of stir-baked SEMEN PSORALEAE with salt solution of 1～4 portion of Lignum Sappan of stir-baked RHIIZOMA CURCUMAE with vinegar
1.5～6 parts of 1～4 part of Radix Astragali of 1～4 portion of Herba Spirodelae of Semen Persicae (parched)
2.5～10 parts of 1.5～6 parts of Radixs Angelicae Dahuricae of 1.5～6 parts of Rhizoma Chuanxiongs of Caulis Spatholobi
2, the leukodermic Chinese medicine preparation of a kind of treatment according to claim 1, wherein the weight proportion of each raw material is:
3～7 parts of 1.5～2.5 parts of salt Semen Astragali Complanatis of 1.5～2.5 parts of Flos Carthamis of stir-baked RHIZOMA SPARGANII with vinegar
3～7 parts of 1.5～2.5 parts of stir-baked SEMEN PSORALEAE with salt solution of 1.5～2.5 portions of Lignum Sappans of stir-baked RHIIZOMA CURCUMAE with vinegar
2.5～3.5 parts of 1.5～2.5 parts of Radix Astragali of 1.5～2.5 portions of Herba Spirodelaes of Semen Persicae (parched)
3～7 parts of 2.5～3.5 parts of Radixs Angelicae Dahuricae of 2.5～3.5 parts of Rhizoma Chuanxiongs of Caulis Spatholobi
3, the leukodermic Chinese medicine preparation of a kind of treatment according to claim 1, wherein the weight proportion of each raw material is:
5 parts of 2 parts of salt Semen Astragali Complanatis of 2 parts of Flos Carthamis of stir-baked RHIZOMA SPARGANII with vinegar
5 parts of 2 parts of stir-baked SEMEN PSORALEAE with salt solution of 2 portions of Lignum Sappans of stir-baked RHIIZOMA CURCUMAE with vinegar
3 parts of 2 parts of Radix Astragali of 2 portions of Herba Spirodelaes of Semen Persicae (parched)
5 parts of 3 parts of Radixs Angelicae Dahuricae of 3 parts of Rhizoma Chuanxiongs of Caulis Spatholobi
4, the Chinese medicine preparation of claim 1-3 is to be fit to medicinal various dosage forms.
5, the Chinese medicine preparation of claim 4 is tablet, capsule, oral liquid, buccal tablet, granule, electuary, pill, powder, suspensoid, powder, solution, drop, drop pill.
6, the Chinese medicine preparation of claim 4 is capsule, tablet, granule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006101405689A CN100546635C (en) | 2006-10-17 | 2006-10-17 | The leukodermic Chinese medicine preparation of a kind of treatment |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006101405689A CN100546635C (en) | 2006-10-17 | 2006-10-17 | The leukodermic Chinese medicine preparation of a kind of treatment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1931340A true CN1931340A (en) | 2007-03-21 |
| CN100546635C CN100546635C (en) | 2009-10-07 |
Family
ID=37877465
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006101405689A Expired - Fee Related CN100546635C (en) | 2006-10-17 | 2006-10-17 | The leukodermic Chinese medicine preparation of a kind of treatment |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100546635C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101199822B (en) * | 2007-12-13 | 2011-10-12 | 张益军 | Capsule medicament for treating qi blood estrangement vitiligo |
-
2006
- 2006-10-17 CN CNB2006101405689A patent/CN100546635C/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101199822B (en) * | 2007-12-13 | 2011-10-12 | 张益军 | Capsule medicament for treating qi blood estrangement vitiligo |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100546635C (en) | 2009-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100473413C (en) | Chinese medicine preparation for treating senile dementia | |
| CN100571736C (en) | A kind of Chinese medicine preparation for the treatment of habitual abortion | |
| CN100496585C (en) | Chloasma treating Chinese medicine preparation | |
| CN103432559A (en) | Traditional Chinese medicine composition for treating spanomenorrhea and dysmenorrhea caused by blood stasis and preparation method and application thereof | |
| CN101897933B (en) | Chinese patent medicament for treating leucoderma | |
| CN104784538A (en) | Chinese medicinal preparation for treating diabetes and preparation method | |
| CN101028362B (en) | Chinese medicine for treating leucoderma | |
| CN100450531C (en) | Chinese medicinal formulation for treating infant bed wetting | |
| CN100546635C (en) | The leukodermic Chinese medicine preparation of a kind of treatment | |
| CN101049370A (en) | Preparation of Chinese traditional medicine for treating leucoderma | |
| CN100571725C (en) | A kind of Chinese medicine preparation for the treatment of sciatica | |
| CN100450537C (en) | Chinese medicinal formulation for treating prostate hyperplasia | |
| CN101028421B (en) | Chinese medicine for treating chronic kidney failure | |
| CN1958028A (en) | Preparation of Chinese traditional medicine for treating hyperplasia of prostate | |
| CN101028492A (en) | Chinese preparation for treating hysteromyoma | |
| CN100546607C (en) | The leukodermic Chinese medicine preparation of a kind of treatment | |
| CN1943766A (en) | A Chinese traditional medicinal preparation for treatment of psoriasis | |
| CN100415289C (en) | A Chinese traditional medicinal preparation for treatment of leukoderma | |
| CN100394948C (en) | Leucoderma treating Chinese medicine prepn | |
| CN100571743C (en) | A kind of Chinese medicine preparation for the treatment of sexual impotence | |
| CN1939463A (en) | Chinese-medicinal preparationf or treating leucoderma | |
| CN100571749C (en) | A kind of Chinese medicine preparation for the treatment of sexual impotence | |
| CN100415276C (en) | A Chinese traditional medicinal preparation for treatment of vitiligo | |
| CN101020032A (en) | Chinese medicine prepn for treating ischemic femoral head necrosis | |
| CN100571730C (en) | A kind of Chinese patent medicine for the treatment of sexual impotence |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: BEIJING WAN SHOU TONG PHARMACEUTICAL TECHNOLOGY C Free format text: FORMER OWNER: WANG XINSUO Effective date: 20080822 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20080822 Address after: Room 230 (Park), No. 19 West Fourth Ring Road South, Beijing, Fengtai District, China: 100071 Applicant after: Beijing Wanshoutong Pharmaceutical Technology Corp. Address before: Beijing Fengtai Changxindian Hospital postal code: 100072 Applicant before: Wang Xinsuo |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: BEIJING SINO-US INNOVATION INSTITUTE OF INTERNATIO Free format text: FORMER OWNER: BEIJING WANSHOUTONG PHARMACEUTICAL TECHNOLOGY CORP. Effective date: 20110415 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100071 ROOM 230 (PARK), NO. 19, WEST 4TH RING ROAD SOUTH, FENGTAI DISTRICT, BEIJING TO: 100076 NO. 10, EAST ALLEY 6, NORTH AREA, MINSHENG ROAD, VILLAGE 4, XIHONGMEN TOWN, DAXING DISTRICT, BEIJING |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20110415 Address after: 100076, No. six, No. 10, North East Road, Minsheng Road, fourth village, Xihongmen Town, Beijing, Daxing District Patentee after: Beijing Sino US Joint Institute of innovation and international difficult diseases Address before: 230, room 19 (Park), No. 100071 West Fourth Ring Road South, Beijing, Fengtai District Patentee before: Beijing Wanshoutong Pharmaceutical Technology Corp. |
|
| ASS | Succession or assignment of patent right |
Owner name: CHEN YUTANG Free format text: FORMER OWNER: BEIJING SINO-US INNOVATION INSTITUTE OF INTERNATIONAL STUBBORN DISEASES Effective date: 20120316 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Chen Yutang Inventor before: Wang Xinsuo |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: WANG XINSUO TO: CHEN YUTANG |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20120316 Address after: 100076, Beijing Town, Daxing District Town, Xihongmen, four village, Minsheng Road, North East six, No. 10 Patentee after: Chen Yutang Address before: 100076, No. six, No. 10, North East Road, Minsheng Road, fourth village, Xihongmen Town, Beijing, Daxing District Patentee before: Beijing Sino US Joint Institute of innovation and international difficult diseases |
|
| ASS | Succession or assignment of patent right |
Owner name: BEIJING SINO-US JOINT INTERNATIONAL DISEASES RESEA Free format text: FORMER OWNER: CHEN YUTANG Effective date: 20120417 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20120417 Address after: 100076, Beijing Daxing District Xihongmen town fourth village Minsheng Road North East six 10, Beijing Sino US Joint Innovation Institute of international difficult disease Chen Zhonghua Dean Patentee after: Beijing Sino US Joint Institute of innovation and international difficult diseases Address before: 100076, Beijing Town, Daxing District Town, Xihongmen, four village, Minsheng Road, North East six, No. 10 Patentee before: Chen Yutang |
|
| ASS | Succession or assignment of patent right |
Owner name: BEIJING SINO-US JOINT INTERNATIONAL DISEASES RESEA Effective date: 20121024 Owner name: BEIJING CHINESE AND FOREIGN INNOVATION INTERNATION Free format text: FORMER OWNER: BEIJING SINO-US JOINT INTERNATIONAL DISEASES RESEARCH INSTITUTE OF INNOVATION Effective date: 20121024 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100076 DAXING, BEIJING TO: 100012 CHAOYANG, BEIJING |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20121024 Address after: 100012 Beijing city Chaoyang District Shangli Road No. 201 Beijing Chinese New International Medical Research Institute Patentee after: Beijing new China International Pharmaceutical Research Institute Patentee after: Beijing Sino US Joint Institute of innovation and international difficult diseases Address before: 100076, Beijing Daxing District Xihongmen town fourth village Minsheng Road North East six 10, Beijing Sino US Joint Innovation Institute of international difficult disease Chen Zhonghua Dean Patentee before: Beijing Sino US Joint Institute of innovation and international difficult diseases |
|
| DD01 | Delivery of document by public notice | ||
| DD01 | Delivery of document by public notice |
Addressee: Beijing new China International Pharmaceutical Research Institute Document name: Notification to Pay the Fees |
|
| DD01 | Delivery of document by public notice |
Addressee: Chen Zhonghua Document name: Notification of Termination of Patent Right |
|
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20091007 Termination date: 20131017 |